Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This vehicle serum is the sham comparator used in clinical trials evaluating the Pavise Extracellular Matrix Restore (ECMR) regimen, specifically in a Phase 2 study led by Goldman, Butterwick, Fitzpatrick and Groff. It is a topical formulation designed to mimic the active ECMR serum in consistency and application but lacks the active nanodiamond-based ingredients. The serum is applied immediately following ablative CO2 and Er:YAG facial laser resurfacing to serve as a control for assessing the efficacy of the active regimen in promoting wound healing and improving skin laxity and photodamage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vehicle serum (Pavise ECMR).